Pharmaceutical Business review

Japan university develops technology to predict anti-cancer products

This technology determines the efficacy of dynamic cellular reaction against target compounds within one hour after the compound is added.

According to the comany, the method will contribute to compound screening for personalized chemotherapy or preventive medicines including anti-cancer, Alzheimer disease, aging (skin care), diabetes, pro-fat burning, metabolism, hair restoration and body temperature.

Kyushu University Professor Toshihiro Ona said they developed surface plasmon resonance sensor (SPR), for biomolecular interaction analysis, besides establishing the method for mitochondrial membrane potential monitor.

The university intends to set up a venture business to manufacture and sell a multi-sample device, to sell patent for interactive combination of compounds.